Subscribe
Logo small
Search
Terapia AML

A breakthrough we still can't benefit from

MedExpress Team

Medexpress

Published Feb. 28, 2022 14:15

A breakthrough we still can't benefit from - Header image
We talk to prof. Sebastian Giebel, hematologist, head of the Clinic of Bone Marrow Transplantation and Oncohematology of the National Oncology Institute Maria Skłodowskiej-Curie, Branch in Gliwice, president of the Association of the Polish Group for the Treatment of Adult Leukemia PALG.

Prof. Sebastian Giebel said among others:

  • Acute myeloid leukemia (AML) is a very aggressive cancer.
  • Without proper treatment, AML can lead to death even within a few or several weeks
  • Treatment should be very ...

    Content locked

    To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

    If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.